Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Her leading-edge research into the processes needed to allow heart cells to regenerate has earned Dr. Phyllis Billia, cardiologist and clinical scientist at the Peter Munk Cardiac Centre, the prestigious Young Investigator Award from the Canadian Cardiovascular Society.
“This national award is an incredible achievement for someone at my level,” said Dr. Billia, whose research team at the Peter Munk Cardiac Centre has presented direct evidence that regeneration of heart cells is possible. “To be recognized by peers nationally is an honour. I am still in the early stages of my career and thought that this achievement would go to someone more worthy. But I was ecstatic when I got an email from the Canadian Cardiovascular Society with the announcement. I had to read it several times to make sure that I was reading it correctly.”
The Canadian Cardiovascular Society acknowledges exceptional individuals for their scientific achievements and contributions. Dr. Billia’s research is both novel and significant in the area of cardiovascular disease. Her research into heart cell regeneration could also potentially be applied to other organs that do not naturally regenerate
(including the kidney and pancreas).
It was her experience as a post-doctoral fellow at the Campbell Family Institute for Cancer Research in Dr. Tak Mak’s laboratory that played a significant role in Dr. Billia’s breakthrough discovery around heart muscle cell regeneration.
“Heart muscle cells are somehow prevented or suppressed from regenerating,” explains Dr. Billia. “If they are damaged during a heart attack, for example, the damage is irreversible. In the cancer world, it is well known that tumour suppressor genes force cancer cells to die rather than regenerate and proliferate. Tumour suppressors also help stop cancer from spreading. In the heart, tumour suppressor genes prevent the heart from regenerating, as well.”
Now Dr. Billia is studying how to manipulate these tumour suppressor genes and refocus them on damaged heart cells – thereby controlling heart regeneration.
“I would categorize my work as being ‘outside the box’,” says Dr. Billia when asked why she thinks the award was given to her. “It is out of the ordinary and takes my exposure to working in a cancer laboratory doing my post-doctoral studies into account. It challenges the dogma of traditional boundaries associated with individual specialties; even people in the tumour suppressor field are intrigued by the results of my work.”
By developing ways to reverse damage done to the heart and allow for the heart to regenerate from within, Dr. Billia’s work holds the possibility to reducing the need for other existing therapies, such as long-term drug therapy and its association with side effects and negative impact on quality of life, or risky surgical interventions.
“While I have been put forth for national awards to support my research and have been very fortunate to receive support from the Canadian Institute for Health Research on several levels, the receipt of this award surpasses what I have received in the past, in terms of recognition from my peers,” says Dr. Billia. “I have a worked a long time to get where I am and this makes it all worthwhile.”